Get started

Ichimokuchart

NQ short below the cloud resistanceMan what a choppy sideways mess. We have been trading around this cloud resistance all week. Almost seems like the market is waiting for something. I think it is waiting on the eventual Trump re-election. All I know is that there is no real movement or momentum. But I have to go with what the market is telling me. Of course this setup is only good until 15:00 HST. After then it will be canceled. Let's see what happens. Entry: 11634.25 SL: 11753 PT: 11500 or lower
OANDA:NAS100USDShort
by Metal-Rules_Rap-Sucks
GBP/USD Rebound - Ichimoku Long SetupThis pair finally broke up and beyond the resistance it's been stuck at. We're in a nice bullish trend and I'm looking for a good entry to try and get long. I've drawn out this setup expecting a drawback to test our previous resistance level which could now act as support. When you trade ichimoku the concept is pretty simple, wait for a trend to establish, then look for a good place to get into. From a high level that's all I'm looking to do in all trades, including this one. I've drawn out some partial profit levels to look for if we can indeed get a drawback and good entry. If support fails to hold, or if our bullish confirmations change, this setup may become invalidated.
Long
by The808Trader
EURGBP, daily timeframe, ascending trend line break downHello my friends, I am currently testing a new interesting screening method for charting and trading. This is the first trade i took with this methods and I am currently testing it to see the performance. I already tried some backtesting so i am gonna try putting it to real trades now. I am going to use the combination of Parabolic SAR and Ichimoku. Sell EURGBP 0.9020-10 Stop loss 0.9080 Take profit 1 @0.8960 Take profit 2 @0.8900 Take profit 3 @0.8840 Disclaimer: I've sold EURGBP from 0.9020 Use only 1-2% risk of your equity Good Luck
Short
by HayatoDragonFX
Space Travel + CESIUM = Possible GamechangerPretium Resources Inc. acquires, explores for, and develops precious metal resource properties in the Americas. The company primarily explores for gold, silver, and copper deposits. Its principal project is the Brucejack project that consists of 4 mining leases and 6 mineral claims covering an area of 3,305.85 hectares located in northwestern British Columbia. It also owns 100% interest in the Snowfield project consisting of 1 mineral claim covering an area of 1,217 hectares located in northern British Columbia. The company was founded in 2010 and is headquartered in Vancouver, Canada. On 06/04/2020, PR Newswire posted a story about Space Travel and an Unknown Metal called Cesium www.prnewswire.com www.prnewswire.com www.kitco.com In the article, it went on to say that Cesium can be used in ion propulsion systems, with 1 kilogram of Cesium used in outer space able to propel a vehicle 140 times as far as any other known liquid or solid, but it could be the game-changer for solar system navigation. Cesium is a critical element of Global Positioning Systems (GPS). Atomic clocks track vibrations inside Cesium to measure time accurately. The same goes for GPS satellites orbiting Earth. It's only because of Cesium that they are able to precisely triangulate. Now, the prospects of deep space make Cesium even more critical. Future missions in deep space could navigate the solar system with a form of GPS-and the defining moment will be the successful testing of the Deep Space Atomic Clock. It will also be a huge part of the brewing "Cold War" with China. The "Cold War" with China is being played out on multiple fronts: Control of critical metals, dominance over 5G, national security and deep space. All these fronts involve Cesium (Cs). China has been in control of almost 100% of the world's Cesium but now, Washington is stepping up its game by adding Cesium to the United States list of critical minerals in 2018. The article also said Pretium Resources (PVG) has an impressive portfolio with a huge opportunity for upside. Construction and engineering activities at its top Cesium location continue to advance, and commercial production is targeted for this year. On 05/01/20, PVG announced earnings that rocked Wall Street Estimates coming in at $0.140 Beats $0.06 Estimate, Sales $126.560 Million Beat $83.480 Million Estimate. Price targets are continuing to rise. On 05/19/20, B. Riley lifted Pretium Resources Price Target to $28 from $27, Keeps Buy Rating. - What does B. Riley know that we don't.??? The Daily Chart looks Bullish Volume is Bullish and rising PMO is trending up, Bullish MACD is trending up, Bullish RSI just crossed up over the center line, Bullish Stochastic is trending up, Bullish Sector is Bullish PVG is getting ready to break out above the cloud. 6-Jul-20 8.53 ▲ Mon PVG New York 6-Jul-20 8.53 Bullish Kijun Sen Cross 2-Jul-20 8.17 Bullish Tenkan/Kijun Cross 19-Jun-20 8.36 Bullish Chikou Span Cross Strong " " Bullish Kumo Breakout Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
PLong
by HotCharts
1
Bullish Charts - Golden Cross, July 6 Conf CallObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. On 06/29/20, ObsEva announced it will hold a conference call to discuss results from Phase 3 PRIMROSE 1 and PRIMROSE 2 clinical trials evaluating their drug Linzagolix in women with Uterine Fibroids. I personally think the conference call will be Bullish because on 07/01/20, ObsEva and Yuyuan BioScience Technology announced submission of the PRE-IND Dossier for Nolasiban with Chinese NMPA. This company has a few things going on that could be a catalyst for the stock moving into July 6, next week. Daily Chart is Bullish 50-Day MA just crossed up above the 200-Day MA - I believe this cross just happened today on above average volume. MACD is turning up, Bullish RSI is Bullish Stochastic is Bullish The Cloud indicators are all Bullish as seen below. 8-May-20 3.36 Bullish Kumo Breakout 5-May-20 2.95 Bullish Senkou Span Cross 4-May-20 2.41 Bullish Kijun Sen Cross 29-Apr-20 2.55 Bullish Tenkan/Kijun Cross 20-Apr-20 2.10 Bullish Chikou Span Cross Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
OLong
by HotCharts
1
Bullish Sector - 5G Play, Golden CrossNokia Corporation engages in the network and technology businesses worldwide. The company operates in four segments: Ultra Broadband Networks, Global Services, IP Networks and Applications, and Nokia Technologies. It focuses on mobile radio including macro radio, small cells, and cloud native radio solutions for communications service providers and enterprises; and provides network planning and optimization, network implementation, and systems integration, as well as company-wide managed services. The company also offers fixed networking solutions, such as copper and fiber access products, solutions, and services. In addition, it provides network infrastructure and professional services for mobile networks; and managed services for the fixed, mobile, Internet protocol (IP), and optical domains. Further, the company offers network planning, implementation, operation, and maintenance services. Additionally, it provides IP/optical networking solutions, including IP routing and optical transport systems, software, and services; software solutions, such as customer experience management, network operations and management, communications and collaborations, policy and charging, as well as Cloud, IoT, security, and analytics platforms; and submarine networks and radio frequency systems. The company has a strategic collaboration with Microsoft. Nokia Corporation was founded in 1865 and is headquartered in Espoo, Finland. Nokia continues receiving 5G contracts. On the Daily Chart, the 50-Day MA is ready to Cross up and over the 200-Day MA, Bullish I think NOK has a shot at reversing its downward trend real soon especially if the USA takes an ownership in the company like many White House officials have been talking about possibly doing to stop China. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NOKLong
by HotCharts
1
Bullish Charts - $15 TargetGenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California. Good earnings report. Daily chart looks amazing. This stock looks like its ready to pop! Long DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
GLong
by HotCharts